Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL179254 | 0.75 | KIF11 (0.39) | RAB9A | |
| SCHEMBL25768087 | 0.74 | ALDH1A1 (0.30) | KDM4ERAB9A | |
| SCHEMBL21287844 | 0.73 | KIF11 (0.32) | POLB | |
| SCHEMBL22328432 | 0.72 | NPC1 (0.36) | RAB9A | |
| SCHEMBL19750612 | 0.72 | ALDH1A1 (0.39) | KDM4EPOLBRAB9A | |
| SCHEMBL11922167 | 0.72 | RAB9A (0.34) | KDM4EPOLBRAB9A | |
| SCHEMBL18909931 | 0.71 | CYP19A1 (0.36) | POLB | |
| SCHEMBL15885025 | 0.71 | CCNA2 (0.36) | — | |
| SCHEMBL20418258 | 0.70 | CYP19A1 (0.35) | KDM4EPOLBRAB9A | |
| SCHEMBL19115699 | 0.70 | MAPT (0.35) | KDM4EPOLBRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234967-A1 | Fused Azole Heterocycles as AHR Antagonists | SAIL BIOMEDICINES, INC. | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234967-A1 | Fused Azole Heterocycles as AHR Antagonists | AHR, ARNT, AIPL1 | KDM4E 1678/4885POLB 3733/4885RAB9A 3800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.